top of page

GPCR News 

Post: Blog2_Post

Ermium Therapeutics has constituted its SAB

Updated: Aug 23, 2022

February 2022

"Ermium Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases"

Read more at the source

#DrGPCR #GPCR #IndustryNews

3 views0 comments

Recent Posts

See All

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin